Advertisement

Index by Author

May 2000; 23 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aburomia, R

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  2. Adams, C

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  3. Ahrén, B

    • Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care May 2000 23:650-657; doi:10.2337/diacare.23.5.650

  4. Akerblom, H K

    • Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care May 2000 23:664-668; doi:10.2337/diacare.23.5.664

  5. Ariëns, R A

    • Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care May 2000 23:703-705; doi:10.2337/diacare.23.5.703

  6. Armstrong, D G

    • Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care May 2000 23:606-611; doi:10.2337/diacare.23.5.606

  7. Atsumi, Y

    • Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance. Diabetes Care May 2000 23:710-712; doi:10.2337/diacare.23.5.710

B

  1. Baker, J

    • Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care May 2000 23:714; doi:10.2337/diacare.23.5.714b

  2. Barta, P

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  3. Bell, C J

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  4. Biderman, A

    • Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel. Diabetes Care May 2000 23:602-605; doi:10.2337/diacare.23.5.602

  5. Binder, J

    • Bilateral diabetic infarction of the anterior tibial muscle. Diabetes Care May 2000 23:699-701; doi:10.2337/diacare.23.5.699a

  6. Bloomgarden, Z T

    • American Diabetes Association annual meeting, 1999: dyslipidemia, endothelial dysfunction, and glycosylation. Diabetes Care May 2000 23:690-698; doi:10.2337/diacare.23.5.690

  7. Boucher, J

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  8. Boulton, A J

    • Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care May 2000 23:634-638; doi:10.2337/diacare.23.5.634

  9. Burns, D K

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  10. Buse, J

    • Insulin glargine (HOE901): first responsibilities: understanding the data and ensuring safety. Diabetes Care May 2000 23:576-578; doi:10.2337/diacare.23.5.576

C

  1. Cheng, J S

    • An equation for insulin sensitivity index. Diabetes Care May 2000 23:712; doi:10.2337/diacare.23.5.712b

  2. Chiarelli, F

    • Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Diabetes Care May 2000 23:712-713; doi:10.2337/diacare.23.5.712a

  3. Choi, C S

    • Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. Diabetes Care May 2000 23:707-708; doi:10.2337/diacare.23.5.707

  4. Chung, Y E

    • Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. Diabetes Care May 2000 23:707-708; doi:10.2337/diacare.23.5.707

  5. Clouse, R E

    • Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care May 2000 23:618-623; doi:10.2337/diacare.23.5.618

  6. Cundy, T

    • Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care May 2000 23:714; doi:10.2337/diacare.23.5.714b

  7. Cupples, L A

    • Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care May 2000 23:669-674; doi:10.2337/diacare.23.5.669

  8. Cypress, M

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

D

  1. D'Agostino, R, Jr

    • Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care May 2000 23:624-628; doi:10.2337/diacare.23.5.624

  2. Davidson, M B

    • Effect of data management on a central server on HbA1c levels in insulin-requiring patients. Diabetes Care May 2000 23:706-707; doi:10.2337/diacare.23.5.706

  3. De Angelis, L

    • Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care May 2000 23:658-663; doi:10.2337/diacare.23.5.658

  4. Dejgaard, A

    • Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. Diabetes Care May 2000 23:675-681; doi:10.2337/diacare.23.5.675

  5. Del Guerra, S

    • Function of pancreatic islets isolated from a type 1 diabetic patient. Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701

  6. Desjardins, D

    • Impact of diabetes on crash risks of truck-permit holders and commercial drivers. Diabetes Care May 2000 23:612-617; doi:10.2337/diacare.23.5.612

  7. Devillé, W L

    • Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction. Diabetes Care May 2000 23:629-633; doi:10.2337/diacare.23.5.629

  8. Di Mario, U

    • Function of pancreatic islets isolated from a type 1 diabetic patient. Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701

  9. Dionne, G

    • Impact of diabetes on crash risks of truck-permit holders and commercial drivers. Diabetes Care May 2000 23:612-617; doi:10.2337/diacare.23.5.612

  10. Dotta, F

    • Function of pancreatic islets isolated from a type 1 diabetic patient. Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701

E

  1. Ekoé, J M

    • Impact of diabetes on crash risks of truck-permit holders and commercial drivers. Diabetes Care May 2000 23:612-617; doi:10.2337/diacare.23.5.612

F

  1. Festa, A

    • Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care May 2000 23:624-628; doi:10.2337/diacare.23.5.624

  2. Freedland, K E

    • Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care May 2000 23:618-623; doi:10.2337/diacare.23.5.618

  3. Friger, M

    • Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel. Diabetes Care May 2000 23:602-605; doi:10.2337/diacare.23.5.602

G

  1. Garg, S K

    • Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care May 2000 23:639-643; doi:10.2337/diacare.23.5.639

  2. Gelder Ehm, M

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  3. Giugliano, D

    • Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care May 2000 23:658-663; doi:10.2337/diacare.23.5.658

  4. Giurini, J M

    • Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care May 2000 23:606-611; doi:10.2337/diacare.23.5.606

  5. Grant, P J

    • Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care May 2000 23:703-705; doi:10.2337/diacare.23.5.703

  6. Griffith, L S

    • Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care May 2000 23:618-623; doi:10.2337/diacare.23.5.618

  7. Grönhagen-Riska, C

    • Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care May 2000 23:664-668; doi:10.2337/diacare.23.5.664

  8. Groop, L

    • Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care May 2000 23:589-594; doi:10.2337/diacare.23.5.589

  9. Guthrie, R A

    • Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care May 2000 23:583-588; doi:10.2337/diacare.23.5.583

H

  1. Haffner, S M

    • Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care May 2000 23:624-628; doi:10.2337/diacare.23.5.624

  2. Hales, C N

    • Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care May 2000 23:624-628; doi:10.2337/diacare.23.5.624

  3. Halvorson, M

    • Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. Diabetes Care May 2000 23:579-582; doi:10.2337/diacare.23.5.579

  4. Hamet, P

    • Impact of diabetes on crash risks of truck-permit holders and commercial drivers. Diabetes Care May 2000 23:612-617; doi:10.2337/diacare.23.5.612

  5. Hanaoka, T

    • Prevalence of diabetes in adult patients with Down's syndrome living in a residential home. Diabetes Care May 2000 23:705-706; doi:10.2337/diacare.23.5.705a

  6. Haneda, M

    • Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b

  7. Harkless, L B

    • Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care May 2000 23:606-611; doi:10.2337/diacare.23.5.606

  8. Harvey, C

    • Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care May 2000 23:606-611; doi:10.2337/diacare.23.5.606

  9. Heinemann, L

    • Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care May 2000 23:644-649; doi:10.2337/diacare.23.5.644

  10. Heine, R J

    • Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction. Diabetes Care May 2000 23:629-633; doi:10.2337/diacare.23.5.629

  11. Heise, T

    • Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care May 2000 23:644-649; doi:10.2337/diacare.23.5.644

  12. Hennerici, M

    • Bilateral diabetic infarction of the anterior tibial muscle. Diabetes Care May 2000 23:699-701; doi:10.2337/diacare.23.5.699a

  13. Hirai, A

    • Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b

  14. Hirsch, I B

    • Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care May 2000 23:639-643; doi:10.2337/diacare.23.5.639

  15. Hollingdal, M

    • Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. Diabetes Care May 2000 23:675-681; doi:10.2337/diacare.23.5.675

  16. Hollis, S

    • Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care May 2000 23:634-638; doi:10.2337/diacare.23.5.634

  17. Hompesch, B

    • Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care May 2000 23:644-649; doi:10.2337/diacare.23.5.644

  18. Hong, S K

    • Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. Diabetes Care May 2000 23:707-708; doi:10.2337/diacare.23.5.707

  19. Hoogma, R P

    • Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction. Diabetes Care May 2000 23:629-633; doi:10.2337/diacare.23.5.629

  20. Hosey, G

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  21. Hsueh, W C

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  22. Hukkanen, L

    • Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care May 2000 23:664-668; doi:10.2337/diacare.23.5.664

I

  1. Iafusco, D

    • Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Diabetes Care May 2000 23:712-713; doi:10.2337/diacare.23.5.712a

  2. Ipp, E

    • Impaired glucose tolerance: the irrepressible alpha-cell? Diabetes Care May 2000 23:569-570; doi:10.2337/diacare.23.5.569

  3. Isomaa, B

    • Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care May 2000 23:589-594; doi:10.2337/diacare.23.5.589

J

  1. Janssen, M M

    • Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction. Diabetes Care May 2000 23:629-633; doi:10.2337/diacare.23.5.629

  2. Joko, M

    • Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b

  3. Jovanovic, L

    • Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care May 2000 23:583-588; doi:10.2337/diacare.23.5.583

  4. Juhl, C B

    • Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. Diabetes Care May 2000 23:675-681; doi:10.2337/diacare.23.5.675

K

  1. Kashiwagi, A

    • Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b

  2. Kaufman, F R

    • Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. Diabetes Care May 2000 23:579-582; doi:10.2337/diacare.23.5.579

  3. Kawabata, T

    • Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b

  4. Kawamori, R

    • Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance. Diabetes Care May 2000 23:710-712; doi:10.2337/diacare.23.5.710

  5. Kiayias, J A

    • Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy. Diabetes Care May 2000 23:699; doi:10.2337/diacare.23.5.699b

  6. Kikkawa, R

    • Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b

  7. Kim, C

    • Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. Diabetes Care May 2000 23:579-582; doi:10.2337/diacare.23.5.579

  8. Kim, S W

    • Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. Diabetes Care May 2000 23:707-708; doi:10.2337/diacare.23.5.707

  9. Kim, Y I

    • Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. Diabetes Care May 2000 23:707-708; doi:10.2337/diacare.23.5.707

  10. Knowler, W C

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  11. Kohler, H P

    • Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care May 2000 23:703-705; doi:10.2337/diacare.23.5.703

  12. Konishi, K

    • Rapid remission of nephrotic-range proteinuria in a case of histologically proven diabetic nephropathy treated with an ACE inhibitor. Diabetes Care May 2000 23:708-710; doi:10.2337/diacare.23.5.708

  13. Kopher, W

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  14. Korpinen, E

    • Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care May 2000 23:664-668; doi:10.2337/diacare.23.5.664

  15. Kurabayashi, M

    • Prevalence of diabetes in adult patients with Down's syndrome living in a residential home. Diabetes Care May 2000 23:705-706; doi:10.2337/diacare.23.5.705a

L

  1. Laberge-Nadeau, C

    • Impact of diabetes on crash risks of truck-permit holders and commercial drivers. Diabetes Care May 2000 23:612-617; doi:10.2337/diacare.23.5.612

  2. Lakka-Papadodima, E

    • Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy. Diabetes Care May 2000 23:699; doi:10.2337/diacare.23.5.699b

  3. Lamb, B

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  4. Larsson, H

    • Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care May 2000 23:650-657; doi:10.2337/diacare.23.5.650

  5. Lasichak, A

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  6. Lee, K U

    • Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. Diabetes Care May 2000 23:707-708; doi:10.2337/diacare.23.5.707

  7. Lee, M S

    • Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. Diabetes Care May 2000 23:707-708; doi:10.2337/diacare.23.5.707

  8. Lee, S I

    • Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. Diabetes Care May 2000 23:707-708; doi:10.2337/diacare.23.5.707

  9. Leiter, L

    • Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care May 2000 23:583-588; doi:10.2337/diacare.23.5.583

  10. Lewis, G

    • Effect of data management on a central server on HbA1c levels in insulin-requiring patients. Diabetes Care May 2000 23:706-707; doi:10.2337/diacare.23.5.706

  11. Li, H

    • Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care May 2000 23:589-594; doi:10.2337/diacare.23.5.589

  12. Ling, Z

    • Function of pancreatic islets isolated from a type 1 diabetic patient. Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701

  13. Linkeschova, R

    • Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care May 2000 23:644-649; doi:10.2337/diacare.23.5.644

  14. Lupi, R

    • Function of pancreatic islets isolated from a type 1 diabetic patient. Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701

  15. Lustman, P J

    • Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care May 2000 23:618-623; doi:10.2337/diacare.23.5.618

M

  1. Maag, U

    • Impact of diabetes on crash risks of truck-permit holders and commercial drivers. Diabetes Care May 2000 23:612-617; doi:10.2337/diacare.23.5.612

  2. Maeda, K

    • Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b

  3. Maeda, T

    • Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b

  4. Mangan, M

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  5. Mansfield, M W

    • Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care May 2000 23:703-705; doi:10.2337/diacare.23.5.703

  6. Marchetti, P

    • Function of pancreatic islets isolated from a type 1 diabetic patient. Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701

  7. Marfella, R

    • Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care May 2000 23:658-663; doi:10.2337/diacare.23.5.658

  8. Marselli, L

    • Function of pancreatic islets isolated from a type 1 diabetic patient. Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701

  9. Masurel, N

    • Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction. Diabetes Care May 2000 23:629-633; doi:10.2337/diacare.23.5.629

  10. Matsuoka, K

    • Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance. Diabetes Care May 2000 23:710-712; doi:10.2337/diacare.23.5.710

  11. McCormack, L J

    • Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care May 2000 23:703-705; doi:10.2337/diacare.23.5.703

  12. Mecca, T E

    • Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care May 2000 23:639-643; doi:10.2337/diacare.23.5.639

  13. Meigs, J B

    • Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care May 2000 23:669-674; doi:10.2337/diacare.23.5.669

  14. Mensing, C

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  15. Messier, S

    • Impact of diabetes on crash risks of truck-permit holders and commercial drivers. Diabetes Care May 2000 23:612-617; doi:10.2337/diacare.23.5.612

  16. Michelsen, B K

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  17. Mitchell, B D

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  18. Mohn, A

    • Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Diabetes Care May 2000 23:712-713; doi:10.2337/diacare.23.5.712a

  19. Mulcahy, K

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  20. Mykkänen, L

    • Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care May 2000 23:624-628; doi:10.2337/diacare.23.5.624

N

  1. Nappo, F

    • Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care May 2000 23:658-663; doi:10.2337/diacare.23.5.658

  2. Nathan, D M

    • Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care May 2000 23:669-674; doi:10.2337/diacare.23.5.669

  3. Navalesi, R

    • Function of pancreatic islets isolated from a type 1 diabetic patient. Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701

  4. Neifing, J L

    • Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care May 2000 23:639-643; doi:10.2337/diacare.23.5.639

  5. Norman, J

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

O

  1. Ohyama, Y

    • Prevalence of diabetes in adult patients with Down's syndrome living in a residential home. Diabetes Care May 2000 23:705-706; doi:10.2337/diacare.23.5.705a

  2. Onuma, T

    • Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance. Diabetes Care May 2000 23:710-712; doi:10.2337/diacare.23.5.710

  3. Ordovas, J M

    • Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care May 2000 23:669-674; doi:10.2337/diacare.23.5.669

P

  1. Palmer, J P

    • Therapeutic importance of subsets of type 2 diabetes? Diabetes Care May 2000 23:574-575; doi:10.2337/diacare.23.5.574

  2. Paolisso, G

    • Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care May 2000 23:658-663; doi:10.2337/diacare.23.5.658

  3. Park, J Y

    • Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria. Diabetes Care May 2000 23:707-708; doi:10.2337/diacare.23.5.707

  4. Pham, H

    • Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care May 2000 23:606-611; doi:10.2337/diacare.23.5.606

  5. Pincus, S

    • Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. Diabetes Care May 2000 23:675-681; doi:10.2337/diacare.23.5.675

  6. Pitukcheewanont, P

    • Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. Diabetes Care May 2000 23:579-582; doi:10.2337/diacare.23.5.579

  7. Pollin, T

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  8. Popp-Snijders, C

    • Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction. Diabetes Care May 2000 23:629-633; doi:10.2337/diacare.23.5.629

  9. Prisco, F

    • Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Diabetes Care May 2000 23:712-713; doi:10.2337/diacare.23.5.712a

  10. Pørksen, N

    • Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. Diabetes Care May 2000 23:675-681; doi:10.2337/diacare.23.5.675

R

  1. Raskin, P

    • Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care May 2000 23:583-588; doi:10.2337/diacare.23.5.583

  2. Ratner, R E

    • Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care May 2000 23:639-643; doi:10.2337/diacare.23.5.639

  3. Rave, K

    • Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care May 2000 23:644-649; doi:10.2337/diacare.23.5.644

  4. Rea, F

    • Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Diabetes Care May 2000 23:712-713; doi:10.2337/diacare.23.5.712a

  5. Realacci, M

    • Function of pancreatic islets isolated from a type 1 diabetic patient. Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701

  6. Riccardi, G

    • Is there any use for the oral glucose tolerance test? Diabetes Care May 2000 23:714-715; doi:10.2337/diacare.23.5.714a

  7. Riis, A

    • Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care May 2000 23:583-588; doi:10.2337/diacare.23.5.583

  8. Rosenblatt, I

    • Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel. Diabetes Care May 2000 23:602-605; doi:10.2337/diacare.23.5.602

  9. Rosen, S

    • Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel. Diabetes Care May 2000 23:602-605; doi:10.2337/diacare.23.5.602

  10. Ruffa, G

    • Is there any use for the oral glucose tolerance test? Diabetes Care May 2000 23:714-715; doi:10.2337/diacare.23.5.714a

S

  1. Sakul, H

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  2. Santangelo, C

    • Function of pancreatic islets isolated from a type 1 diabetic patient. Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701

  3. Saruta, T

    • Rapid remission of nephrotic-range proteinuria in a case of histologically proven diabetic nephropathy treated with an ACE inhibitor. Diabetes Care May 2000 23:708-710; doi:10.2337/diacare.23.5.708

  4. Schaefer, E J

    • Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care May 2000 23:669-674; doi:10.2337/diacare.23.5.669

  5. Schiffrin, A

    • Nighttime continuous subcutaneous insulin infusion revisited: a strategy for improving insulin delivery. Diabetes Care May 2000 23:571-573; doi:10.2337/diacare.23.5.571

  6. Schmitz, O

    • Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. Diabetes Care May 2000 23:675-681; doi:10.2337/diacare.23.5.675

  7. Schwartz, A

    • Bilateral diabetic infarction of the anterior tibial muscle. Diabetes Care May 2000 23:699-701; doi:10.2337/diacare.23.5.699a

  8. Sedlak, M

    • Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care May 2000 23:644-649; doi:10.2337/diacare.23.5.644

  9. Shalev, R

    • Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel. Diabetes Care May 2000 23:602-605; doi:10.2337/diacare.23.5.602

  10. Shimada, A

    • Rapid remission of nephrotic-range proteinuria in a case of histologically proven diabetic nephropathy treated with an ACE inhibitor. Diabetes Care May 2000 23:708-710; doi:10.2337/diacare.23.5.708

  11. Shuldiner, A R

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  12. Singer, D E

    • Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care May 2000 23:669-674; doi:10.2337/diacare.23.5.669

  13. Snoek, F J

    • Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction. Diabetes Care May 2000 23:629-633; doi:10.2337/diacare.23.5.629

  14. Spengos, K

    • Bilateral diabetic infarction of the anterior tibial muscle. Diabetes Care May 2000 23:699-701; doi:10.2337/diacare.23.5.699a

  15. St Jean, P L

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  16. Sturis, J

    • Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. Diabetes Care May 2000 23:675-681; doi:10.2337/diacare.23.5.675

  17. Suzuki, R

    • Rapid remission of nephrotic-range proteinuria in a case of histologically proven diabetic nephropathy treated with an ACE inhibitor. Diabetes Care May 2000 23:708-710; doi:10.2337/diacare.23.5.708

T

  1. Tagliamonte, M R

    • Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care May 2000 23:658-663; doi:10.2337/diacare.23.5.658

  2. Tanaka, Y

    • Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance. Diabetes Care May 2000 23:710-712; doi:10.2337/diacare.23.5.710

  3. Tanja, J

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  4. Taskinen, M R

    • Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care May 2000 23:589-594; doi:10.2337/diacare.23.5.589

  5. Teppo, A M

    • Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care May 2000 23:664-668; doi:10.2337/diacare.23.5.664

  6. Terada, M

    • Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b

  7. Tomono, S

    • Prevalence of diabetes in adult patients with Down's syndrome living in a residential home. Diabetes Care May 2000 23:705-706; doi:10.2337/diacare.23.5.705a

  8. Tuomi, T

    • Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care May 2000 23:589-594; doi:10.2337/diacare.23.5.589

U

  1. Uchiyama, T

    • Prevalence of diabetes in adult patients with Down's syndrome living in a residential home. Diabetes Care May 2000 23:705-706; doi:10.2337/diacare.23.5.705a

  2. Utsugi, T

    • Prevalence of diabetes in adult patients with Down's syndrome living in a residential home. Diabetes Care May 2000 23:705-706; doi:10.2337/diacare.23.5.705a

V

  1. Vaarala, O

    • Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care May 2000 23:664-668; doi:10.2337/diacare.23.5.664

  2. Vaccaro, O

    • Is there any use for the oral glucose tolerance test? Diabetes Care May 2000 23:714-715; doi:10.2337/diacare.23.5.714a

  3. van Schie, C H

    • Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care May 2000 23:634-638; doi:10.2337/diacare.23.5.634

  4. Veldhuis, J D

    • Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. Diabetes Care May 2000 23:675-681; doi:10.2337/diacare.23.5.675

  5. Veves, A

    • Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care May 2000 23:606-611; doi:10.2337/diacare.23.5.606

  6. Vileikyte, L

    • Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care May 2000 23:634-638; doi:10.2337/diacare.23.5.634

  7. Vlachou, E D

    • Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy. Diabetes Care May 2000 23:699; doi:10.2337/diacare.23.5.699b

W

  1. Wagner, M J

    • Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595

  2. Weinger, K

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  3. Weitzman, S

    • Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel. Diabetes Care May 2000 23:602-605; doi:10.2337/diacare.23.5.602

  4. Whalley, A

    • Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care May 2000 23:634-638; doi:10.2337/diacare.23.5.634

  5. Wignall, T

    • Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care May 2000 23:634-638; doi:10.2337/diacare.23.5.634

  6. Wilson, C A

    • Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care May 2000 23:639-643; doi:10.2337/diacare.23.5.639

  7. Wilson, P W

    • Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care May 2000 23:669-674; doi:10.2337/diacare.23.5.669

  8. Wisdom, K

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

  9. Wöhrle, J C

    • Bilateral diabetic infarction of the anterior tibial muscle. Diabetes Care May 2000 23:699-701; doi:10.2337/diacare.23.5.699a

Y

  1. Yasuda, H

    • Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b

  2. Yauk, L

    • National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682

Z

  1. Zangwill, L M

    • Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel. Diabetes Care May 2000 23:602-605; doi:10.2337/diacare.23.5.602

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement